nani treatment in Psoriasis.
Phase 2
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2020/03/023875
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically stable patients of Plaque psoriasis
Exclusion Criteria
Patients below and above the age of 18 and 60 years respectively.
Patient suffering from concomitant skin diseases like Dermatophytosis, Eczema, Lichen Simplex & Seborrheic Dermatitis.
Patient suffering from severe systemic and metabolic diseases.
Diabetic and HIV patient.
Pregnant & Lactating Women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation for prognosis with averaged PASITimepoint: 0th,15th day, 30th day and 45th day
- Secondary Outcome Measures
Name Time Method Dermatological Life Quality Index (DLQI) <br/ ><br>Change in Photograph of skin lesion. <br/ ><br>Timepoint: 0th,15th day, 30th day and 45th day